Designing B-Cell Epitopes for Immunotherapy and Subunit Vaccines
- 1 January 2015
- book chapter
- Published by Springer Nature
- Vol. 1348, 327-340
Abstract
Rationally designed subunit vaccines mainly consist of small peptides or B-cell epitopes, which can stimulate the body’s immune response. Development of subunit vaccines is a very tedious and costly process. One of the imperative and crucial steps of vaccine development is the identification of highly competent B-cell epitopes as most of the proteins and fragments of proteins are immunologically irrelevant. With the advances in bioinformatics tools, it can be possible to precisely narrow down potential B-cell epitopes from the whole proteome of any pathogen. This chapter sheds light on prediction and designing of B-cell epitopes using two in silico tools LBtope and IgPred.Keywords
This publication has 18 references indexed in Scilit:
- Prediction of IL4 Inducing PeptidesJournal of Immunology Research, 2013
- Designing of interferon-gamma inducing MHC class-II bindersBiology Direct, 2013
- Identification of B-cell epitopes in an antigen for inducing specific class of antibodiesBiology Direct, 2013
- Future directions for peptide therapeutics developmentDrug Discovery Today, 2013
- Improved Method for Linear B-Cell Epitope Prediction Using Antigen’s Primary SequencePLOS ONE, 2013
- IgE and mast cells in allergic diseaseNature Medicine, 2012
- Advances in the design and delivery of peptide subunit vaccines with a focus on Toll-like receptor agonistsExpert Review of Vaccines, 2010
- Identification of conformational B-cell Epitopes in an antigen from its primary sequenceImmunome Research, 2010
- Synthetic therapeutic peptides: science and marketDrug Discovery Today, 2010
- More than one reason to rethink the use of peptides in vaccine designNature Reviews Drug Discovery, 2007